Jeanne Griffin Tuthill, MA, CCC-SLP | |
228 Pleasant St, Northampton, MA 01060-3913 | |
(413) 588-5266 | |
(413) 584-8592 |
Full Name | Jeanne Griffin Tuthill |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 228 Pleasant St, Northampton, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003440488 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 5079 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jeanne Griffin Tuthill, MA, CCC-SLP 50 Deepwoods Dr, Amherst, MA 01002-3248 Ph: (413) 256-8777 | Jeanne Griffin Tuthill, MA, CCC-SLP 228 Pleasant St, Northampton, MA 01060-3913 Ph: (413) 588-5266 |
News Archive
Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis.
Scientists have a developed a new technique to decipher how millions of individual cells are communicating with each other in miniature tumors grown in the lab, known as organoids, according to new research published in Nature Methods today (Monday).
The blood inventory of New York Blood Center, the majority supplier of blood to New York and New Jersey hospitals, has dropped to crisis proportions.
The U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce and distribute influenza vaccine for the United States.
The Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRA, (fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients with multiple sclerosis (MS) who have shown improvement after eight weeks of treatment.
› Verified 3 days ago
Karen Laclair, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 N King St, Northampton, MA 01060 Phone: 413-585-1400 | |
Ms. Amy Bleiweiss X, SPEECH LANGUAGE PATH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 53 Clark Ave, Unit 2, Northampton, MA 01060 Phone: 413-582-1811 | |
Ms. Beverly Mara Blatt, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 243 King St, Suite 242, Northampton, MA 01060 Phone: 413-584-0265 Fax: 413-584-2031 | |
Renee Riley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 N King St, Northampton, MA 01060 Phone: 413-585-1400 | |
Danielle Baker, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 228 King St Ste 2, Northampton, MA 01060 Phone: 413-727-8552 | |
Ms. Lori Allison Fromowitz, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Winter St Apt 2, Northampton, MA 01060 Phone: 206-383-3810 |